Creating a new microscope for detailed skin imaging
Development of a fast scanning, extended field-of-view multiphoton microscope for clinical skin imaging
This study is testing a new type of microscope that helps doctors see how immune cells interact in the skin, which could improve the way we understand and treat skin conditions like autoimmune diseases and skin cancers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11091420 on NIH RePORTER |
What this research studies
This research focuses on developing a cutting-edge multiphoton microscope designed for clinical skin imaging. By utilizing advanced imaging techniques, the project aims to visualize immune cell interactions within human skin, which is crucial for understanding conditions like autoimmune diseases and skin cancers. The new device, known as iFLAME, will allow for rapid and detailed imaging without the need for labeling, providing insights into immune responses in real-time. This innovative approach could significantly enhance the diagnosis and treatment of various skin conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune skin conditions such as atopic dermatitis or allergic eczema.
Not a fit: Patients with non-autoimmune skin conditions or those not requiring detailed immune cell imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for skin-related autoimmune diseases and cancers.
How similar studies have performed: Previous research using multiphoton microscopy has shown promise in understanding immune responses, suggesting that this approach could yield valuable insights in a clinical setting.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Balu, Mihaela — University of California-Irvine
- Study coordinator: Balu, Mihaela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.